| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 54.534 | 95.745 | 140.259 | 118.790 | 104.481 | 75.373 | 64.010 |
| Total Income - EUR | - | - | 0 | 54.549 | 95.766 | 141.579 | 118.790 | 106.456 | 75.881 | 64.026 |
| Total Expenses - EUR | - | - | 1.076 | 48.732 | 89.641 | 124.265 | 110.894 | 101.402 | 78.337 | 75.266 |
| Gross Profit/Loss - EUR | - | - | -1.076 | 5.817 | 6.125 | 17.315 | 7.897 | 5.054 | -2.456 | -11.240 |
| Net Profit/Loss - EUR | - | - | -1.076 | 4.190 | 4.844 | 16.183 | 6.851 | 4.011 | -3.215 | -12.128 |
| Employees | - | - | 0 | 0 | 1 | 2 | 0 | 2 | 1 | 1 |
Check the financial reports for the company - Vet Pharm Exim S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 0 | 0 | 4.088 | 3.562 | 2.449 | 4.960 | 3.875 | 2.848 |
| Current Assets | - | - | 78 | 10.929 | 22.943 | 32.029 | 28.332 | 15.833 | 15.471 | 19.252 |
| Inventories | - | - | 0 | 7.009 | 10.855 | 17.828 | 14.084 | 11.673 | 12.841 | 17.374 |
| Receivables | - | - | 34 | 3.680 | 11.395 | 13.885 | 14.060 | 3.721 | 1.158 | 867 |
| Cash | - | - | 44 | 240 | 693 | 316 | 189 | 439 | 1.471 | 1.011 |
| Shareholders Funds | - | - | -1.032 | 3.177 | 4.905 | 16.233 | 17.280 | 4.068 | -2.192 | -14.308 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 1.110 | 7.751 | 22.126 | 19.358 | 13.501 | 16.726 | 21.537 | 36.408 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7500 - 7500" | |||||||||
| CAEN Financial Year |
7500
|
|||||||||
Comments - Vet Pharm Exim S.r.l.